Foreign company claims cancer cure, doctors skeptical


Hang on for a minute...we're trying to find some more stories you might like.


Email This Story






An Israeli company is claiming they have developed a cure for one of the most notorious incurable diseases in history, but many critics are already doubting the probability of such broad claims. The biotech company, Accelerated Evolution Biotechnologies Ltd. (AEBi), has made several claims that within one year, they will have developed a cure for any type of cancer. They also claim the cure will have “no or minimal side-effects at a much lower cost than most other treatments on the market” and “ will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects,” according to the founder, Dan Aridor.

  Their treatment is called MuTaTo (multi-target toxin) and works by targeting cancer cells directly by preventing the cells from mutating. It’s been compared to an antibiotic in the way it works. AEBi claims that their MuTaTo treatment is capable of destroying cancer cells faster than they can replicate, as it can attack multiple targets at once, hence the name multi-target toxin. They also announced that the cure will be in both generic and personalized treatments.

  Despite all these promising statements, there is a lot of opposition to AEBi’s claims. In fact, at this time, there’s an overwhelming amount of evidence to oppose AEBi’s claims. Many cancer research organizations, health groups, and medical professionals are already questioning the likelihood of such a cure being plausible.

  Perhaps the largest flaw in this AEBi’s claims is their credibility. The only news source that has interviewed this company was the Jerusalem Post, and their article showed no opposition to the claims made, suggesting potential bias. Not to mention that AEBi has not been a leading health organization. On top of that, AEBi has no other proof other than their word that their treatment will be effective, as well as having it commercially available within a year’s time. Their reasoning behind this is they “can’t afford” to publish their medical research, yet any credible and reputable medical and/or scientific journal charges nothing to publish, as long as the research is serious. And with claims such as the one’s AEBi are making, they’d have to be serious. Several other credible sources have already claimed this could simply just be a publicity stunt to receive funding, attention, etc.

  Not only is the company’s credibility questionable, but as well as the plausibility of something like this. J. Leonard Lichtenfeld, MD, MACP, a Deputy Chief Medical Officer for the national office of the American Cancer Society (ACA) recently released an article where he addresses several key points as to why this treatment and these claims must be taken with a grain of salt. To sum up Dr. Len’s article, he says the news report is not credible, their tests are only based on “exploratory” experiments conducted on mice, they still face much more difficult testing, and most importantly, it’s simply not probable that this company could develop and overcome all his previous key points within a year. This is especially amplified by the fact that they are an underdeveloped company when compared to something as the ACA, who claims even they couldn’t pull off something like this, especially within a year’s time.

  “There’s so many different types of cancer, that’s the problem,” Sherry Rupp, Skyline’s nurse, said. “Some cancers are closer to developing cures, others not so much, even then I wouldn’t expect any real cures till at least maybe 2025”.

  Lichtenfeld isn’t the only scientist opposing AEBi’s claims either. In fact, the only real source that has suggested AEBi as credible and truthful in their claims is the Jerusalem post, and AEBi themselves. This fact, in and of itself, can debunk the claims made by AEBi.

  Overall this “cure,” while albeit not impossible, is just so improbably the perfect product, that it is extremely unlikely the company will be able to pull through with their claims. The general rule of thumb that everybody knows is if something is too good to be true, it most likely is, and this “cure” is likely no exception.

Print Friendly, PDF & Email

Hang on for a minute...we're trying to find some more stories you might like.


Email This Story